Table 2 The identified upregulated and downregulated DEGs-set.

From: Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing

Upregulated genes: \({DEG}_{UR}=\left({A}_{UR}\cup {B}_{UR}\right)\cap {C}^{/}\) (n = 16)

Downregulated genes: \({DEG}_{DR}=\left({A}_{DR}\cup {B}_{DR}\right)\cap {C}^{/}\)

(n = 91)

APLNR, CD79B, ITM2C, METTL24, PPP1R1A, RNU1-28P, RNU1-3, RP11-488L18.8, ATPIF1, FOLR2, H19, ICAM2, IGF2, NDUFA8, PLVAP, SNRPD2

AC007278.2, AC007278.3, AC009303.1, AC068580.6, ACER3, AP001189.4, ARL5B, BEST1, CCL18, CCL20, CD300E, CTB89H12.4, CTD2537I9.18, CXCL2, CYP1B1, CYR61, DESI2, DGKH, DUSP6, EDN1, ENPP4, ERAP2, GAPDHP59, GK, GLDN, GUCY1A2, HS3ST2,IGFN1, IGSF10, KLF6, LRRTM2, MTND1P23, NAMPTP1, NAV2-AS4, NAV2-AS5, NCR3LG1, NEDD9, NLRP3, NUPL1, NUS1, OGFRL1, OSBPL8, PAG1, PTP4A1, PZP, RASGEF1B, RNU2-61P, RP1-257A7.4, RP1-309I22.2, RP11-107E5.3, RP11-212I21.3, RP11-288K12.1, RP11-314N13.9, RP11-350J20.4, RP11-359E10.1, RP11-380G5.3, RP11-417F21.1, RP11-437B10.1, RP11-463O12.5, RP11-571F15.3, RP11-603J24.5, RP11-83B20.6, RP11-925D8.6, RP11-93B14.9, RP5-1101C3.1, RPL18P10, RRM2B, RSPO4, SDCBPP1, SDK2, SERPINB2, SLC16A6, SLC30A7, SLC5A8, SLC6A6, SLC7A11, SLC7A11-AS1, SLED1, SPDYA, SSXP10, TAF9BP1, TCF21, TLR2, TRHDE, TSPAN19, TSPAN3, UPP1, USP53, VGLL3, ZFAND5, ZFP36

[The gene symbols in bold indicate hub DEGs that are obtained by PPI network analysis]

Back to article page